{
    "2018-04-13": [
        [
            {
                "time": "2018-04-15",
                "original_text": "Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III",
                "features": {
                    "keywords": [
                        "NVS",
                        "AveXis",
                        "PFE",
                        "ABBV",
                        "Phase III"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Pharma",
                        "Q1 Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "Better Buy: AbbVie Inc. vs. Eli Lilly",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "Exploring Voyager Therapeuticsâ€™ Research Pipeline",
                "features": {
                    "keywords": [
                        "Voyager Therapeutics",
                        "Research Pipeline"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "Another Shot At This 4-Time Winner -- If We Act Quickly",
                "features": {
                    "keywords": [
                        "4-Time Winner"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Fujifilm",
                        "Kyowa",
                        "Humira",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}